Activation of CD4-positive T lymphocyte

Activation of CD4-positive T lymphocyte refers to the process by which naïve CD4+ T cells are stimulated by antigen-presenting cells (APCs), usually dendritic cells, through their T cell receptor (TCR) binding to antigenic peptides presented on major histocompatibility complex class II (MHC II) molecules, along with essential co-stimulatory signaling (e.g., via CD28), leading to intracellular signaling cascades involving kinases, transcription factors (e.g., NFAT, NF-κB, AP-1), and metabolic changes. This activation is essential for initiation and regulation of the adaptive immune response, resulting in proliferation, differentiation into subsets (such as Th1, Th2, Th17, Tfh, Treg), and cytokine production. Dysregulation of this process underlies a wide range of pathologies, from immunodeficiency to autoimmunity[1][3][5][6][9]. *Note*: For structured target information, identify and specify the particular **molecule** involved in this process (e.g., "CD4", "T cell receptor", "CD28", "CTLA-4" etc.) rather than the cellular activation event itself, which is a composite and not a single molecular entity.

Other names

CD4-positive T cell activationCD4 T cell activationT helper cell activationTh cell activationactivation of T helper lymphocyte

Modulation of co-stimulatory/inhibitory signals (e.g., CTLA-4 blockade enhances T cell activation) - Inhibition of intracellular signaling (e.g., calcineurin inhibitors suppress T cell activation by blocking NFAT) - Blockade of T cell receptor signaling pathways